X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-12-11 | AORT | Holloway Jean F | SVP, GC | S - Sale | $30.13 | -8,070 | 153,862 | -5% | -$243,109 | ||||||
| A | 2024-12-06 | AORT | Horton Amy | VP, Chief Accounting Officer | S - Sale | $29.05 | -4,425 | 135,564 | -3% | -$128,552 | |||||
2024-12-06 | AORT | Horton Amy | VP, Chief Accounting Officer | S - Sale | $29.66 | -4,329 | 135,660 | -3% | -$128,398 | ||||||
2024-12-04 | AORT | Green Andrew M | VP Regulatory | S - Sale | $30.00 | -7,618 | 33,503 | -19% | -$228,540 | ||||||
| D | 2024-10-01 | AORT | Horton Amy | VP, Chief Accounting Officer | S - Sale+OE | $26.18 | -12,430 | 139,989 | -8% | -$325,415 | |||||
2024-08-26 | AORT | Holloway Jean F | SVP, GC | S - Sale | $26.55 | -3,167 | 161,932 | -2% | -$84,096 | ||||||
2024-08-16 | AORT | Getz Matthew A | VP, HR | S - Sale | $25.31 | -9,420 | 34,116 | -22% | -$238,434 | ||||||
2024-08-15 | AORT | Holloway Jean F | SVP, GC | S - Sale | $25.76 | -2,383 | 165,099 | -1% | -$61,393 | ||||||
2024-08-13 | AORT | Semedo Anthony B. | Dir | S - Sale | $24.99 | -9,709 | 34,159 | -22% | -$242,628 | ||||||
2024-05-10 | AORT | Holloway Jean F | SVP, GC | S - Sale | $23.42 | -1,250 | 167,482 | -1% | -$29,275 | ||||||
2024-05-09 | AORT | Holloway Jean F | SVP, GC | S - Sale | $23.79 | -979 | 168,732 | -1% | -$23,286 | ||||||
2024-03-20 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $20.39 | -2,183 | 83,296 | -3% | -$44,511 | ||||||
2024-03-15 | AORT | Green Andrew M | VP Regulatory | S - Sale | $20.00 | -1,462 | 41,121 | -3% | -$29,240 | ||||||
2024-03-14 | AORT | Green Andrew M | VP Regulatory | S - Sale | $20.00 | -3,994 | 42,583 | -9% | -$79,880 | ||||||
2024-03-12 | AORT | Getz Matthew A | VP, HR | S - Sale | $19.94 | -5,000 | 43,536 | -10% | -$99,720 | ||||||
| A | 2024-02-26 | AORT | Horton Amy | VP, Chief Accounting Officer | S - Sale | $20.27 | -2,134 | 137,888 | -2% | -$43,259 | |||||
| A | 2024-02-26 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $20.27 | -3,007 | 81,726 | -4% | -$60,955 | |||||
| A | 2024-02-26 | AORT | Maney Rochelle L. | VP, Quality | S - Sale | $20.27 | -2,282 | 44,518 | -5% | -$46,259 | |||||
| A | 2024-02-26 | AORT | Holloway Jean F | SVP, GC | S - Sale | $20.27 | -2,838 | 166,852 | -2% | -$57,529 | |||||
| A | 2024-02-26 | AORT | Green Andrew M | VP Regulatory | S - Sale | $20.27 | -2,367 | 44,580 | -5% | -$47,982 | |||||
| A | 2024-02-26 | AORT | Davis John E | Chief Commercial Officer | S - Sale | $20.27 | -3,461 | 162,572 | -2% | -$70,158 | |||||
| A | 2024-02-27 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $19.83 | -465 | 81,261 | -1% | -$9,223 | |||||
| A | 2024-02-27 | AORT | Maney Rochelle L. | VP, Quality | S - Sale | $19.83 | -370 | 44,148 | -1% | -$7,339 | |||||
| A | 2024-02-27 | AORT | Green Andrew M | VP Regulatory | S - Sale | $19.83 | -421 | 44,159 | -1% | -$8,350 | |||||
| A | 2024-02-27 | AORT | Horton Amy | VP, Chief Accounting Officer | S - Sale | $19.83 | -325 | 137,563 | 0% | -$6,446 | |||||
| A | 2024-02-27 | AORT | Davis John E | Chief Commercial Officer | S - Sale | $19.83 | -584 | 161,988 | 0% | -$11,583 | |||||
| A | 2024-02-26 | AORT | Mackin James P | Pres, CEO | S - Sale | $20.27 | -30,836 | 696,253 | -4% | -$625,080 | |||||
| A | 2024-02-27 | AORT | Holloway Jean F | SVP, GC | S - Sale | $19.83 | -485 | 166,367 | 0% | -$9,620 | |||||
| A | 2024-03-05 | AORT | Horton Amy | VP, Chief Accounting Officer | S - Sale | $18.72 | -1,152 | 139,989 | -1% | -$21,568 | |||||
| A | 2024-03-01 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $18.72 | -1,506 | 85,479 | -2% | -$28,195 | |||||
| A | 2024-02-26 | AORT | Getz Matthew A | VP, HR | S - Sale | $20.27 | -2,280 | 46,440 | -5% | -$46,218 | |||||
| A | 2024-02-27 | AORT | Getz Matthew A | VP, HR | S - Sale | $19.83 | -325 | 46,115 | -1% | -$6,446 | |||||
| A | 2024-03-05 | AORT | Maney Rochelle L. | VP, Quality | S - Sale | $18.72 | -1,157 | 46,569 | -2% | -$21,662 | |||||
| A | 2024-02-27 | AORT | Mackin James P | Pres, CEO | S - Sale | $19.83 | -4,837 | 691,416 | -1% | -$95,939 | |||||
| A | 2024-03-05 | AORT | Holloway Jean F | SVP, GC | S - Sale | $18.72 | -2,380 | 169,711 | -1% | -$44,559 | |||||
| A | 2024-03-05 | AORT | Green Andrew M | VP Regulatory | S - Sale | $18.72 | -1,160 | 46,577 | -2% | -$21,718 | |||||
| A | 2024-03-05 | AORT | Getz Matthew A | VP, HR | S - Sale | $18.72 | -1,157 | 48,536 | -2% | -$21,661 | |||||
| A | 2024-03-05 | AORT | Davis John E | Chief Commercial Officer | S - Sale | $18.72 | -2,022 | 165,690 | -1% | -$37,856 | |||||
| A | 2024-03-05 | AORT | Mackin James P | Pres, CEO | S - Sale | $18.72 | -13,996 | 706,038 | -2% | -$262,037 | |||||
2024-03-05 | AORT | Mackin James P | Pres, CEO | S - Sale | $18.72 | -13,996 | 705,562 | -2% | -$262,037 | ||||||
2024-03-05 | AORT | Holloway Jean F | SVP, GC | S - Sale | $18.72 | -2,380 | 169,669 | -1% | -$44,559 | ||||||
2024-03-05 | AORT | Davis John E | Chief Commercial Officer | S - Sale | $18.72 | -2,022 | 165,637 | -1% | -$37,856 | ||||||
2024-03-05 | AORT | Getz Matthew A | VP, HR | S - Sale | $18.72 | -1,157 | 48,503 | -2% | -$21,661 | ||||||
2024-03-05 | AORT | Maney Rochelle L. | VP, Quality | S - Sale | $18.72 | -1,157 | 46,536 | -2% | -$21,662 | ||||||
2024-03-05 | AORT | Green Andrew M | VP Regulatory | S - Sale | $18.72 | -1,160 | 46,541 | -2% | -$21,718 | ||||||
2024-03-05 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $18.72 | -1,506 | 85,438 | -2% | -$28,195 | ||||||
2024-03-05 | AORT | Horton Amy | VP, Chief Accounting Officer | S - Sale | $18.72 | -1,152 | 139,957 | -1% | -$21,568 | ||||||
2024-02-27 | AORT | Tyrs Florian | VP, Global Operations | S - Sale | $19.83 | -339 | 25,689 | -1% | -$6,724 | ||||||
2024-02-27 | AORT | Horton Amy | VP, Chief Accounting Officer | S - Sale | $19.83 | -325 | 137,531 | 0% | -$6,446 | ||||||
2024-02-27 | AORT | Mackin James P | Pres, CEO | S - Sale | $19.83 | -4,837 | 690,940 | -1% | -$95,939 | ||||||
2024-02-27 | AORT | Holloway Jean F | SVP, GC | S - Sale | $19.83 | -485 | 166,325 | 0% | -$9,620 | ||||||
2024-02-27 | AORT | Davis John E | Chief Commercial Officer | S - Sale | $19.83 | -584 | 161,935 | 0% | -$11,583 | ||||||
2024-02-27 | AORT | Maney Rochelle L. | VP, Quality | S - Sale | $19.83 | -370 | 44,115 | -1% | -$7,339 | ||||||
2024-02-27 | AORT | Getz Matthew A | VP, HR | S - Sale | $19.83 | -325 | 46,082 | -1% | -$6,446 | ||||||
2024-02-27 | AORT | Green Andrew M | VP Regulatory | S - Sale | $19.83 | -421 | 44,123 | -1% | -$8,350 | ||||||
2024-02-27 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $19.83 | -465 | 81,220 | -1% | -$9,223 | ||||||
2024-02-26 | AORT | Holloway Jean F | SVP, GC | S - Sale | $20.27 | -2,880 | 166,810 | -2% | -$58,381 | ||||||
2024-02-26 | AORT | Maney Rochelle L. | VP, Quality | S - Sale | $20.27 | -2,315 | 44,485 | -5% | -$46,928 | ||||||
2024-02-26 | AORT | Davis John E | Chief Commercial Officer | S - Sale | $20.27 | -3,514 | 162,519 | -2% | -$71,233 | ||||||
2024-02-26 | AORT | Getz Matthew A | VP, HR | S - Sale | $20.27 | -2,313 | 46,407 | -5% | -$46,887 | ||||||
2024-02-26 | AORT | Green Andrew M | VP Regulatory | S - Sale | $20.27 | -2,403 | 44,544 | -5% | -$48,711 | ||||||
2024-02-26 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $20.27 | -3,048 | 81,685 | -4% | -$61,786 | ||||||
2024-02-26 | AORT | Tyrs Florian | VP, Global Operations | S - Sale | $20.27 | -893 | 26,065 | -3% | -$18,103 | ||||||
2024-02-20 | AORT | Holloway Jean F | SVP, GC | S - Sale | $18.87 | -3,527 | 131,858 | -3% | -$66,537 | ||||||
2024-02-20 | AORT | Horton Amy | VP, Chief Accounting Officer | S - Sale | $18.87 | -1,695 | 122,345 | -1% | -$31,976 | ||||||
2024-02-20 | AORT | Davis John E | Chief Commercial Officer | S - Sale | $18.87 | -2,556 | 128,177 | -2% | -$48,219 | ||||||
2024-02-20 | AORT | Maney Rochelle L. | VP, Quality | S - Sale | $18.87 | -407 | 29,123 | -1% | -$7,678 | ||||||
2024-02-20 | AORT | Getz Matthew A | VP, HR | S - Sale | $18.87 | -1,695 | 28,692 | -6% | -$31,976 | ||||||
2024-02-20 | AORT | Tyrs Florian | VP, Global Operations | S - Sale | $18.87 | -249 | 19,174 | -1% | -$4,697 | ||||||
| D | 2024-02-20 | AORT | Mackin James P | Pres, CEO | S - Sale+OE | $18.85 | -72,069 | 539,036 | -12% | -$1,358,818 | |||||
| D | 2024-01-02 | AORT | Holloway Jean F | SVP, GC | S - Sale+OE | $18.00 | -21,229 | 133,520 | -14% | -$382,122 | |||||
| D | 2024-01-02 | AORT | Davis John E | SVP, Global Sales | S - Sale+OE | $18.00 | -13,562 | 128,733 | -10% | -$244,116 | |||||
| D | 2023-12-15 | AORT | Horton Amy | VP, Chief Accounting Officer | S - Sale+OE | $19.00 | -14,397 | 124,040 | -10% | -$273,543 | |||||
2023-11-27 | AORT | Horton Amy | VP, Chief Accounting Officer | S - Sale | $17.34 | -2,101 | 103,849 | -2% | -$36,431 | ||||||
2023-06-06 | AORT | Maier Dennis B | SVP, Operations | S - Sale | $15.27 | -16,254 | 34,724 | -32% | -$248,163 | ||||||
2023-06-07 | AORT | Getz Matthew A | VP, HR | S - Sale | $15.88 | -6,329 | 30,387 | -17% | -$100,483 | ||||||
2023-03-02 | AORT | Maier Dennis B | SVP, Operations | S - Sale | $13.41 | -1,121 | 50,978 | -2% | -$15,035 | ||||||
2023-03-02 | AORT | Maney Rochelle L. | VP, Quality | S - Sale | $13.41 | -821 | 29,530 | -3% | -$11,011 | ||||||
2023-03-02 | AORT | Horton Amy | VP, Chief Accounting Officer | S - Sale | $13.41 | -702 | 107,700 | -1% | -$9,415 | ||||||
2023-03-02 | AORT | Getz Matthew A | VP, HR | S - Sale | $13.41 | -702 | 36,716 | -2% | -$9,415 | ||||||
2023-03-02 | AORT | Mackin James P | Pres, CEO | S - Sale | $13.41 | -9,990 | 551,880 | -2% | -$133,984 | ||||||
2023-03-02 | AORT | Green Andrew M | VP Regulatory | S - Sale | $13.41 | -825 | 25,567 | -3% | -$11,065 | ||||||
2023-03-02 | AORT | Lee David Ashley | EVP, COO, CFO | S - Sale | $13.41 | -1,401 | 369,777 | 0% | -$18,790 | ||||||
2023-03-02 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $13.41 | -907 | 52,077 | -2% | -$12,165 | ||||||
2023-03-02 | AORT | Davis John E | SVP, Global Sales | S - Sale | $13.41 | -1,121 | 128,733 | -1% | -$15,035 | ||||||
2023-03-02 | AORT | Holloway Jean F | SVP, GC | S - Sale | $13.41 | -907 | 133,520 | -1% | -$12,165 | ||||||
2023-02-27 | AORT | Horton Amy | VP, Chief Accounting Officer | S - Sale | $12.94 | -1,419 | 106,112 | -1% | -$18,359 | ||||||
2023-02-27 | AORT | Lee David Ashley | EVP, COO, CFO | S - Sale | $12.94 | -3,094 | 366,599 | -1% | -$40,030 | ||||||
2023-02-27 | AORT | Holloway Jean F | SVP, GC | S - Sale | $12.94 | -1,960 | 130,764 | -1% | -$25,358 | ||||||
2023-02-27 | AORT | Davis John E | SVP, Global Sales | S - Sale | $12.94 | -2,393 | 126,191 | -2% | -$30,961 | ||||||
| M | 2023-02-27 | AORT | Maney Rochelle L. | VP, Quality | S - Sale | $13.03 | -1,284 | 28,061 | -4% | -$16,733 | |||||
2023-02-27 | AORT | Green Andrew M | VP Regulatory | S - Sale | $12.94 | -1,747 | 24,102 | -7% | -$22,603 | ||||||
2023-02-27 | AORT | Mackin James P | Pres, CEO | S - Sale | $12.94 | -22,630 | 540,052 | -4% | -$292,787 | ||||||
2023-02-27 | AORT | Maier Dennis B | SVP, Operations | S - Sale | $12.94 | -2,330 | 48,436 | -5% | -$30,146 | ||||||
2023-02-27 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $12.94 | -2,337 | 49,321 | -5% | -$30,236 | ||||||
2023-02-27 | AORT | Getz Matthew A | VP, HR | S - Sale | $12.94 | -1,600 | 35,128 | -4% | -$20,701 | ||||||
| D | 2023-02-17 | AORT | Horton Amy | VP, Chief Accounting Officer | S - Sale+OE | $14.09 | -18,000 | 100,935 | -15% | -$253,553 | |||||
| D | 2023-02-14 | AORT | Lee David Ashley | EVP, COO, CFO | S - Sale+OE | $13.22 | -31,900 | 358,123 | -8% | -$421,874 | |||||
| D | 2023-02-14 | AORT | Mackin James P | Pres, CEO | S - Sale+OE | $13.22 | -56,500 | 505,684 | -10% | -$747,207 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |